特朗普称孕期服用泰诺会增加胎儿患自闭症风险！各方这样看

Core Viewpoint - The recent statement by President Trump regarding the potential risk of acetaminophen (Tylenol) use during pregnancy and its association with autism has sparked significant discussion and concern in the medical community and among pharmaceutical companies [1][3]. Group 1: Company Responses - The manufacturer of Tylenol, after reviewing existing scientific evidence, maintains that acetaminophen does not cause autism, a view supported by credible public health and medical professionals [3]. - The company emphasizes the importance of consulting healthcare professionals before taking any over-the-counter medications during pregnancy [3][5]. Group 2: Regulatory and Scientific Perspectives - The FDA has been monitoring the topic for over a decade and has conducted multiple reviews since 2014, maintaining its recommendation for acetaminophen use during pregnancy without changing the drug's labeling information [3]. - The World Health Organization (WHO) stated that while some observational studies suggest a potential link between prenatal exposure to acetaminophen and autism, the existing evidence is inconsistent, with several studies finding no such association [4]. - The European Medicines Agency has not found any evidence linking Tylenol use during pregnancy to autism, and there is currently no need to modify existing recommendations in the EU [4]. Group 3: Medical Community Insights - Experts highlight that autism is a complex neurodevelopmental disorder with rising global prevalence, currently estimated at about 1%, with significant increases observed in the U.S. from 1 in 150 in 2000 to 1 in 44 in 2020 [4][5]. - Medical professionals advise that while acetaminophen remains a primary choice for fever and pain relief during pregnancy, it is crucial to weigh the risks and benefits and to avoid unnecessary use [5].